Anticancer compounds as leishmanicidal drugs: Challenges in Chemotherapy and future perspectives

Current Medicinal Chemistry

Volumn 15, Issue 5, 2008, Pages 433-439

  Fuertes, Miguel A ^a   Nguewa, Paul A ^b   Castilla, Josefina ^c   Alonso, Carlos ^a   Pérez, José Manuel ^c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c Farmacia Castilla   (Spain)

Author keywords

Anticancer drugs; Apoptosis; Leishmanicidal drugs; Necrosis

Indexed keywords

8 QUINOLINOL DERIVATIVE; 9 ANILINOACRIDINE DERIVATIVE; AMPHOTERICIN B; AMSACRINE; ANTILEISHMANIAL AGENT; ANTINEOPLASTIC AGENT; ANTIPROTOZOAL AGENT; CISPLATIN; DIHYDROARTEMISININ DERIVATIVE; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); EDELFOSINE; EFLORNITHINE; FLUOROURACIL; GERMACRANOLIDE DERIVATIVE; ILMOFOSINE; INDOLEACETIC ACID DERIVATIVE; MEGLUMINE ANTIMONATE; MELARSOPROL; MILTEFOSINE; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; PENTAMIDINE; PENTAMIDINE DERIVATIVE; PENTAMIDINE ISETHIONATE; PHOSPHOLIPID DERIVATIVE; PLATINUM COMPLEX; STIBOGLUCONATE SODIUM; SURAMIN; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROTOZOAL ACTIVITY; BABESIOSIS; CELL DEATH; CYTOTOXICITY; DNA REPLICATION; DNA TRANSCRIPTION; DRUG COST; DRUG DESIGN; DRUG EFFICACY; DRUG RESEARCH; DRUG STRUCTURE; HUMAN; IN VITRO STUDY; INHIBITION KINETICS; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LEISHMANIASIS; LEUKEMIA CELL LINE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MORTALITY; PATHOGENESIS; PNEUMOCYSTOSIS; REVIEW; SKIN LEISHMANIASIS; STRUCTURE ACTIVITY RELATION; TRYPANOSOMIASIS; UNSPECIFIED SIDE EFFECT;

AMSACRINE; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIPROTOZOAL AGENTS; APOPTOSIS; DNA TOPOISOMERASES, TYPE II; HUMANS; LEISHMANIA; LEISHMANIASIS; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; ORGANOPLATINUM COMPOUNDS; OXYQUINOLINE; PHOSPHOLIPIDS;

EID: 41549148210     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986708783503221     Document Type: Review

References (77)

1. Croft, S.L.; Coombs, G.H. Trends Parasitol., 2003, 19, 502.
2. Guerin, P.L; Olliaro, P.; Sundar, S.; Boclaert, M.; Croft, S.L.; Desjeux, P.; Wasunna, M.; Bryceson, A.D.M. Lancet Infect. Dis., 2002, 2, 494.
3. Singh, S.; Sivakumar, R. J. Infect. Chemother., 2004, 10, 307.
4. Sereno, D.; Lemesre, J. L. Antimicrob. Agents Chemother., 1997, 41, 972.
5. Klinkert, M.Q.; Heussler, V. Mini. Rev. Med. Chem., 2006, 6, 131.
6. Ouassi, A., Ouassi, M. Arch. Immunol. Therp. Exp., 2005, 53, 102.
7. Fuertes, M.A.; Nguewa, P.; Castilla, J., Alonso, C.; Pérez, J.M. In Programmed Cell Death in Protozoa; José Manuel Pérez, Ed.; Springer Science-Landes Bioscience, New York, 2007, pp. 1-6.
8. Georgopoulo, K.; Smirlis, D., Bisti, S., Xingi, E.; Skaltsounis, L.; Soteriadou, K. Planta Med., 2007, 73, 1081.
9. Papageorgiou, I.G.; Yakob, L.; Al Salabi, M.I.; Diallinas, G.; Soteriadou, K.P.; De Koning, H.P. Parasitology, 2005, 130, 275.
10. Werbovetz, K.A.; Lehnert, E.K.; Macdonald, T.L.; Pearson, R.D. Antimicrob. Agents Chemother., 1992, 36, 495.
11. Baguley, B. C.; Holdaway, K. M.; Fray, L. M. J Natl. Cancer Inst., 1990, 82, 398.
12. Liu, L. F. Ann. Rev. Biochem., 1989, 58, 351.
13. Harvey, V. J.; Hardy, J. R.; Smith, S.; Grove, W.; Baguley, B. C. Eur. J. Cancer, 1991, 27, 1617.
14. Jehn,U.; Heinemann, V. Anticancer Res., 1991, 11, 705.
15. Chen, K.M.; Sun,, Y.W., Tang, T.W.; Sun, Z.Y.; Kwon, C.H. Mol. Pharm., 2005, 2, 118.
16. Bacherikov, V.A.; Chou, T.C.; Dong, H.C.; Chen, C.H.; Lin, Y.W.; Tsai, T.J.; Su, T.L. Bioorg. Med. Chem. Lett., 2004, 14, 4719.
17. Su, T.L.; Lin, Y.W.; Chou, T.C.; Zhang, X.; Bacherikov, V.A.; Chen, C.H.; Liu, L.F., Tsai, T.J. J. Med Chem., 2006, 49, 3710.
18. Arlin, Z. A. Cancer Treat. Rep., 1983, 67, 967
19. Miller, L. P.; Pyesmany, A. F.; Wolff, L. J.; Rogers, P. C.; Siegel, S. E.; Wells, R. J.; Buckley, J. D.; Hammond, G. D. Cancer, 1991, 67, 2235.
20. Mauel, J.; Denny, W.; Gamage, S.; Ransijn, A.; Wojcik, S.; Figgitt, D.; Ralph, R. Antimicrob. Agents Chemother., 1993, 37, 991.
21. Gamage, S. A.; Figgitt, D. P.; Wojcik, S. J.; Ralph, R. K.; Ransijn, A.; Mauel, J.; Yardley, V.; Snowdon, D.; Croft, S. L.; Denny, W. A. J. Med. Chem., 1997, 40, 2634.
22. Shen, A. Y.; Chen, C. P.; Roffler, S. Life Sci., 1999, 64, 813.
23. Collery, P.; Lechenault, F.; Cazabat, A.; Juvin, E.; Khassanova, L.; Evangelou, A.; Keppler, B. Anticancer Res., 2000, 20,955.
24. Tzeng, C. C.; Lee, K. H.; Wang, T. C.; Han, C. H., Chen, Y. L. Pharm. Res., 2000, 17, 715.
25. Lentz, D. L.; Gershon, H.; Marini, H. Mycopathologia, 1999, 147, 117.
26. Dardari, Z.; Lemrani, M.; Bahloul, A.; Sebban, A.; Hassar, M.; Kitane, S.; Berrada, M.; Boudouma, M. Farmaco, 2004, 59, 195.
27. Mishra, J.; Saxena, A.; Singh, S. Curr. Med. Chem., 2007, 14, 1153.
28. Azzouz, S.; Maache, M.; Dos Santos, M.F.; Sarciron, M.E.; Petavy, A.F.; Osura, A. J. Parasitol., 2005, 92, 877.
29. Benveniste, J.; Tence, M.; Varenne, P.; Bidault, J.; Boullet, C.; Polonsky, J. C. R. Seances Acad. Sci. D., 1979, 289, 1037.
30. Demopoulos, C. A.; Pinckard, R. N.; Hanahan, D. J. J. Biol. Chem., 1979, 254, 9355.
31. Croft, S. L.; Neal, R. A.; Pendergast W.; Chan, J. H. Biochem. Pharmacol., 1987, 36, 2633.
32. Croft, S. L.; Snowdon, D.; Yardley, V. J. Antimicrob. Chemother., 1996, 38, 1041.
33. Singh, S. J. Parasit. Dis., 1996, 20,185.
34. Achterberg, V; Gercken, G. Mol. Biochem. Parasitol., 1987, 23, 117.
35. Achterberg, V.; Gercken, G. Mol. Biochem. Parasitol., 1987, 26, 277.
36. Croft, S. L.; Neal, R. A.; Thornton, E. A.; Herrmann, D. B. Trans. R. Soc. Trop. Med. Hyg., 1993, 87, 217.
37. Escobar, P.; Mato, S.; Marques, C.; Croft, S. L. Acta Trop., 2002, 81, 151.
38. Lux, H.; Hart, D. T.; Parker, P. J.; Klenner, T. Adv. Exp. Med. Biol., 1996, 416 201.
39. Lira, R.; Contreras, L. M.; Rita, R. M.; Urbina, J. A. J. Antimicrob. Chemother., 2001, 47, 537.
40. Konstantinov, S. M.; Kaminsky, R.; Brun, R.; Berger, M. R.; Zillmann, U. Acta Trop., 1997, 64, 145.
41. Haase, R.; Wieder, T.; Geilen, C. C.; Reutter, W. FEBS Lett., 1991, 288, 129.
42. Wieder, T.; Orfanos, C. E.; Geilen, C. C. J. Biol. Chem., 1998, 273, 11025.
43. Konstantinov, S. M.; Eibl, H.; Berger, M. R. Cancer Chemother. Pharmacol., 1998, 41, 210.
44. Mollinedo, F.; Fernandez-Luna, J. L.; Gajate, C.; Martin-Martin, B.; Benito, A.; Martinez-Dalmau, R.; Modolell, M. Cancer Res., 1997, 57, 1320.
45. Brachwitz, H.; Vollgraf, C. Pharmacol. Ther., 1995, 66, 39.
46. Arthur, G.; Bittman, R. Biochim. Biophys. Acta, 1998, 1390, 85.
47. Wieder, T.; Reutter, W.; Orfanos, C. E.; Geilen, C. C. Prog. Lipid Res., 1999, 38, 249.
48. Rybczynska, M.; Spitaler, M.; Knebel, N. G.; Boeck, G.; Grunicke, H.; Hofmann, J. Biochem. Pharmacol., 2001, 62, 765
49. Croft S. L.; Seifert, K.; Duchene, M. Mol. Biochem. Parasitol., 2003, 126, 165.
50. Santa-Rita, R. M.; Santos, B. H.; Meirelles, M. N.; de Castro, S. L. Acta Trop., 2000, 75, 219.
51. Engelmann, J.; Henke, J.; Willker, W.; Kutscher, B.; Nossner, G.; Engel, J.; Leibfritz, D. Anticancer Res. 1996, 16, 1429
52. Berkovic, D.; Fleer, E. A., Eibl, H.; Unger, C. Prog. Exp. Tumor Res., 1992, 34, 59.
53. Perez-Victoria, J. M.; Perez-Victoria, F. J.; Parodi-Talice, A.; Jimenez, I. A.; Ravelo, A. G.; Castanys, S.; Gamarro, F. Antimicrob. Agents Chemother., 2001, 45, 2468.
54. Sindermann, J. R.; Skaletz-Rorowski, A.; Bartels, A.; Hohage, H.; Plenz, G,; Schmidt, A.; Breithardt, G. Basic Res. Cardiol., 2002, 97, 125.
55. Martin, C.; Oldfiel, E.; Urbina, J. A.; Docampo, R.; WO0220478 (2002).
56. Shanahan, F.; Prendergast, G.C.: WO200253138 (2002).
57. Mahmoud, A. E.; Waseem, G.: WO2006002105 (2006).
58. Perez, J. M.; Fuertes, M. A.; Alonso, C.; Navarro-Ranninger, C. Crit. Rev. Oncol. Hematol., 2000, 35, 109.
59. Pérez, J.M.; Kelland, L.R.; Montero, E.I.; Boxall, F.; Fuertes, M.A.; Alonso, C.; Navarro-Ranninger, C. Mol. Pharmacol., 2003, 63, 933.
60. Fuertes, M.A.; Alonso, C.; Pérez, J.M,. Chem. Rev., 2003, 103, 645.
61. DeConti, R. C.; Toftness, B. R.; Lange, R. C.; Creasey, W. A. Cancer Res., 1973, 33, 1310.
62. Gullo, J. J.; Litterst, C. L.; Maguire, P. J.; Sikic, B. I.; Hoth, D. F.; Woolley, P. V. Cancer Chemother. Pharmacol., 1980, 5, 21.
63. Espinosa, E.; Feliu, J.; Zamora, P.; Gonzalez, B. M.; Sanchez, J. J.; Ordon, E. A.; Espinosa, J. Lung Cancer, 1995, 12, 67.
64. Holding, J. D.; Lindup, W. E.; van Laer. C.; Vreeburg, C. C.; Schilling, V.; Wilson, J. A.; Stell, P. M. Br. J. Clin. Pharmacol., 1992, 33, 75.
65. Yunmbam, M. K.; Li, Q. Q.; Mimnaugh, E. G.; Kayastha, G. L.; Yu, J. J.; Jones, L. N.; Neckers, L.; Reed, E. Int. J. Oncol., 2001, 19, 741.
66. Fuertes, M. A.; Castilla, J.; Alonso, C.; Perez, J. M. Curr. Med. Chem., 2003, 10, 257.
67. Natile, G.; Coluccia, M. Met. Ions Biol. Syst., 2004, 42, 209.
68. Osuna, A.; Ruiz-Perez, L. M.; Lopez, M. C.; Castanys, S.; Gamarro, F.; Craciunescu, D. G.; Alonso, C. J. Parasitol., 1987, 73, 272.
69. Mbongo, N.; Loiseau, P. M.; Lawrence, F.; Bories, Craciunescu, D. G.; Robert-Gero, M. Parasitol. Res., 1997, 83, 515
70. Najajreh, Y.; Perez, J. M.; Navarro-Ranninger, C.; Gibson, D. J. Med. Chem., 2002, 45, 5189.
71. Nguewa, P.; Fuertes, M.A.; Iborra, S.; Najareh, Y.; Gibson, D.; Martinez, E.; Alonso, C., Péréz, J.M. J. Inorg. Biochem., 2005, 99, 727.
72. Cushion, M. T.; Walzer, P. D.; Collins, M. S.; Rebholz, S.; Vanden Eynde, J. J.; Mayence, A.; Huang, T. L. Antimicrob. Agents Chemother., 2004, 48, 4209.
73. Borges, M. N.; Messeder, J. C.; Figueroa-Villar, J. D. Eur. J. Med. Chem., 2004, 39, 925.
74. Sands, M.; Kron, M. A.; Brown, R. B. Rev. Infect. Dis., 1985, 7, 625.
75. Murray, H. W.; Hariprasbad, J.; Fichtl, R. E. Antimicrob. Agents Chemother., 1993, 37, 1504.
76. Nguewa, P. A.; Fuertes, M. A.; Cepeda, V.; Iborra, S.; Carrión, J.; Valladares, B.; Alonso, C.; Perez, J. M. Chemistry & Biodiversity, 2005, 2, 1387.
77. Pathak, M. K.; Dhawan, D.; Linder, D. J.; Borden E. C.; Farver, U.; Yi, T. Mol. Cancer Ther., 2002, 1, 1255.